FX.co ★ Inovio Pharmaceuticals Inc. Q3 Loss Narrows

Inovio Pharmaceuticals Inc. (INO) has released its third-quarter financial results, showing an improvement in its loss compared to the same period last year. The company recorded a loss of $25.17 million, or $0.89 per share, for the quarter. This is a notable reduction from the previous year's third-quarter loss of $33.93 million, or $1.52 per share.

Key Financial Highlights (GAAP) for Inovio Pharmaceuticals Inc. for the Third Quarter:

- Earnings: Loss of $25.17 million, compared to a loss of $33.93 million in the previous year.

- Earnings Per Share (EPS): Loss of $0.89, compared to a loss of $1.52 last year.